Trial of Deferiprone in Parkinson's Disease.
N Engl J Med
; 387(22): 2045-2055, 2022 12 01.
Article
in En
| MEDLINE
| ID: mdl-36449420
Full text:
1
Database:
MEDLINE
Main subject:
Parkinson Disease
/
Substantia Nigra
/
Iron Chelating Agents
/
Deferiprone
/
Iron
/
Antiparkinson Agents
Type of study:
Clinical_trials
Language:
En
Journal:
N Engl J Med
Year:
2022
Type:
Article